Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 8, 2014, Pages 885-892

  Oliván, Sara ^a   Martínez Beamonte, Roberto ^a,b   Calvo, Ana C ^a   Surra, Joaquín C ^a,b   Manzano, Raquel ^a   Arnal, Carmen ^a,b   Osta, Rosario ^a   Osada, Jesús ^a,b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Autophagy; Cu Zn superoxide dismutase 1; Extra virgin olive oil; Palm oil; Reticulum stress; SOD1G93A mice

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BECLIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE REGULATED PROTEIN 78; MYOD1 PROTEIN; MYOGENIC FACTOR; OLIVE OIL; ATF6 PROTEIN, MOUSE; CHOLESTEROL; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; PALM OIL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; VEGETABLE OIL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FAT INTAKE; LIPID DIET; LOCOMOTION; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; MUSCLE CELL; NONHUMAN; ANIMAL; DRUG EFFECTS; FEMALE; GENETICS; LONGEVITY; MALE; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALIA; MUS; MUS MUSCULUS;

ACTIVATING TRANSCRIPTION FACTOR 6; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; CHOLESTEROL; ENDOPLASMIC RETICULUM STRESS; FEMALE; HEAT-SHOCK PROTEINS; LONGEVITY; MALE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCLE FIBERS, SKELETAL; PLANT OILS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84903771194     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.04.005     Document Type: Article

References (39)

1. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
2. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993, 261:1047-1051.
3. Barber S.C., Mead R.J., Shaw P.J. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 2006, 1762:1051-1067.
4. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1995, 92:689-693.
5. Barbeito A.G., Mesci P., Boillee S. Motor neuron-immune interactions: the vicious circle of ALS. J Neural Transm 2010, 117:981-1000.
6. Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J.L., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 2004, 101:11159-11164.
7. Fergani A., Oudart H., Gonzalez De Aguilar J.L., Fricker B., Rene F., Hocquette J.F., et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 2007, 48:1571-1580.
8. Mattson M.P., Cutler R.G., Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 2007, 9:17-20.
9. Pedersen W.A., Mattson M.P. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res 1999, 833:117-120.
10. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 2008, 8:425-436.
11. Martinez-Gonzalez M.A., Sanchez-Villegas A., De Irala J., Marti A., Martinez J.A. Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr Neurosci 2002, 5:65-73.
12. Scarmeas N., Luchsinger J.A., Schupf N., Brickman A.M., Cosentino S., Tang M.X., et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009, 302:627-637.
13. Estruch R., Ros E., Salas-Salvado J., Covas M.I., Corella D., Aros F., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368:1279-1290.
14. Lopez-Miranda J., Perez-Jimenez F., Ros E., De Caterina R., Badimon L., Covas M.I., et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010, 20:284-294.
15. Guillen N., Acin S., Navarro M.A., Surra J.C., Arnal C., Lou-Bonafonte J.M., et al. Knowledge of the biological actions of extra virgin olive oil gained from mice lacking apolipoprotein E. Rev Esp Cardiol 2009, 62:294-304.
16. Calleja L., Paris M.A., Paul A., Vilella E., Joven J., Jimenez A., et al. Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 1999, 19:2368-2375.
17. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
18. Navarro M.A., Carpintero R., Acin S., Arbones-Mainar J.M., Calleja L., Carnicer R., et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 2005, 31:52-63.
19. Martinez-Beamonte R., Navarro M.A., Acin S., Guillen N., Barranquero C., Arnal C., et al. Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil. PLoS ONE 2013, 8:e55231.
20. Navab M., Hama S.Y., Hough G.P., Subbanagounder G., Reddy S.T., Fogelman A.M. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 2001, 42:1308-1317.
21. Surra J.C., Barranquero C., Torcal M.P., Orman I., Segovia J.C., Guillen N., et al. In comparison with palm oil, dietary nut supplementation delays the progression of atherosclerotic lesions in female apoE-deficient mice. Br J Nutr 2013, 109:202-209.
22. Calvo A.C., Manzano R., Atencia-Cibreiro G., Olivan S., Munoz M.J., Zaragoza P., et al. Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice. PLoS ONE 2012, 7:e32632.
23. Manzano R., Toivonen J.M., Olivan S., Calvo A.C., Moreno-Igoa M., Munoz M.J., et al. Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2011, 8:386-396.
24. Nuno-Ayala M., Guillen N., Navarro M.A., Lou-Bonafonte J.M., Arnal C., Gascon S., et al. Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency. Atherosclerosis 2010, 212:268-273.
25. Ramirez-Torres A., Barcelo-Batllori S., Martinez-Beamonte R., Navarro M.A., Surra J.C., Arnal C., et al. Proteomics and gene expression analyses of squalene-supplemented mice identify microsomal thioredoxin domain-containing protein 5 changes associated with hepatic steatosis. J Proteomics 2012, 77:27-39.
26. Coll T., Eyre E., Rodriguez-Calvo R., Palomer X., Sanchez R.M., Merlos M., et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 2008, 283:11107-11116.
27. Salvado L., Coll T., Gomez-Foix A.M., Salmeron E., Barroso E., Palomer X., et al. Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 2013, 56:1372-1382.
28. Ozcan L., Tabas I. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu Rev Med 2012, 63:317-328.
29. Homma K., Fujisawa T., Tsuburaya N., Yamaguchi N., Kadowaki H., Takeda K., et al. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol Cell 2013, 52:75-86.
30. Eschbach J., Schwalenstocker B., Soyal S.M., Bayer H., Wiesner D., Akimoto C., et al. PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet 2013, 22:3477-3484.
31. Bernardini C., Censi F., Lattanzi W., Barba M., Calcagnini G., Giuliani A., et al. Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. PLoS ONE 2013, 8:e57739.
32. Dupuis L., Loeffler J.P. Amyotrophic lateral sclerosis: role of energy deficiency in neuromuscular junction dismantlement. Med Sci (Paris) 2008, 24:1077-1082.
33. Musaro A. State of the art and the dark side of amyotrophic lateral sclerosis. World J Biol Chem 2010, 1:62-68.
34. Wills A.M., Hubbard J., Macklin E.A., Glass J., Tandan R., Simpson E.P., et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet 2014, Feb 27 [pii: S0140-6736(14)60222-1].
35. Giordano E., Davalos A., Nicod N., Visioli F. Hydroxytyrosol attenuates tunicamycin-induced endoplasmic reticulum stress in human hepatocarcinoma cells. Mol Nutr Food Res 2014, 58:954-962.
36. Decuypere J.P., Paudel R.C., Parys J., Bultynck G. Intracellular Ca signaling: a novel player in the canonical mTOR-controlled autophagy pathway. Commun Integr Biol 2013, 6:e25429.
37. Onesto E., Rusmini P., Crippa V., Ferri N., Zito A., Galbiati M., et al. Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. J Neurochem 2011, 118:266-280.
38. Katsiki M., Chondrogianni N., Chinou I., Rivett A.J., Gonos E.S. The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts. Rejuvenation Res 2007, 10:157-172.
39. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.